This study was designed to investigate the effect of tacrolimus (FK506
) and of cyclosporine (CsA) on tubular function in renal graft recipie
nts. Patients were randomised after renal transplantation to immunosup
pressive treatment with FK506 (n = 8) or CsA (n = 8), Patients had a m
ean age of 45.7 +/- 3.4 yr; there was no difference in age, sex, HLA s
tatus or CMV mismatches. Neither was there any difference in the frequ
ency of episodes of acute kidney failure between the groups, nor was t
here a significant difference in the frequency of episodes of kidney r
ejection within the first year. The mean FK506 level at the time lay a
t 14.7 +/- 14.4 ng/mL whole blood, and the mean CsA level at the time
of study was 162 +/- 25 ng/mL whole blood. We performed renal function
studies 6 months after transplantation: C-In, C-PAH, NaHCO3 loading,
and Na2SO4 loading. There was no significant impairment of GFR in pati
ents treated with FK506 with 53.6 +/- 2.5 mL/min as compared to 58 +/-
6 mt in group 2. Plasma renin activity (0.6 +/- 0.4 ng/mL vs 2.3 +/-
3; p < 0.01) and aldosterone (69 +/- 17 vs 157 +/- 28.2 pg/mL; p < 0.0
5) were significantly decreased during treatment with FK506. Fractiona
l HCO3 excretion was low in both groups, indicating that bicarbonate r
eabsorption in the proximal nephron was unimpaired. Distal renal tubul
ar acidosis was demonstrated in 4 patients of group 1 but in only 1 of
group 2. Potassium levels were slightly increased in patients treated
with FK506 (5.4 +/- 0.2 mmoL/L) as compared to cyclosporine (4.9 +/-
0.3 mmoL/L; p < 0.05). Distal hydrogen ion secretion, evaluated by the
ability to increase urinary pCO(2) in a highly alkaline urine, was im
paired in patients treated with FK506 (U-B pCO(2): 16.1 +/- 4 vs 36 +/
- 5.8; p < 0.05) as compared to patients treated with CsA. The maximum
acidification capability (NAE) was slightly lowered during therapy wi
th FK506 (67.5 +/- 11.8 versus 86.6 +/- 16.5 mu mol/min, ns). We concl
ude that FK506 administration results in a decrease in the rate of hyd
rogen ion secretion by the collecting tubules. This defect was disclos
ed by the finding of a subnormal pCO(2) in a highly alkaline urine. Th
ese results show that FK506 is able to induce distal tubular acidosis.
Distal tubular acidosis is part of FK506 induced nephrotoxicity, the
pathogenesis of this type of hyperkalemic metabolic acidosis found in
patients treated with FK506 after renal transplantation has to be furt
her elucidated.